Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit

Clinics in Perinatology

Volumn 27, Issue 3, 2000, Pages 655-679

  Sola, Martha C ^a   Del Vecchio, Antonio ^b   Rimsza, Lisa M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Azienda Ospedaliera A Di Summa   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL INDIUM IN 111; AGGLUTININ; CYTOKINE; HEPARIN; HLA ANTIGEN; IMMUNOGLOBULIN; INDOMETACIN; QUININE; RECOMBINANT INTERLEUKIN 11; RECOMBINANT THROMBOPOIETIN; RNA; THIAZIDE DIURETIC AGENT; THROMBOCYTE ANTIGEN; THROMBOPOIETIN;

CLINICAL TRIAL; DISEASE ASSOCIATION; GENETIC DISORDER; HUMAN; INCIDENCE; INFECTION; NEWBORN INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0033848036     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70044-0     Document Type: Article

References (191)

1. Platelet counts in thriving premature infants
2. Neonatal adenovirus infection: Four patients and review of the literature
3. Profile of enteroviurs disease in the first two weeks of life
4. Megakaryocytopoiesis in the human fetus
5. Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia
6. Sagittal sinus thrombosis associated with thrombocytopenia: A report of two patients
7. Classification and aetiology of the aplastic anemias
8. The bone marrow failure syndromes
9. Developmental hemostasis: Relevance to newborns and infants
10. Neonatal thrombocytopenia
11. Heparin-induced thrombocytopenia: A prospective study
12. Clinical relevance of gestational thrombocytopenia of <100,000/μL
13. A randomized, double-blind placebo controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia
14. Significance of platelets with increased RNA content (reticulated platelets)
15. Occurrence of myeloproliferative disorder in patients with Noonan syndrome
16. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia
17. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression but defective reactivity to thrombopoietin
18. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl
19. Randomized, blinded placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer
20. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer
21. Naked megakaryocyte nuclei as an indicator of human immunodeficiency virus infection
22. Thrombocytopenia caused by immunologic platelet destruction: Idiopathic thrombocytopenic purpura, drug-induced thrombocytopenia and miscellaneous forms
23. Neonatal alloimmune thrombocytopenia: A clinical perspective
24. Platelet disorders in newborn infants: Diagnosis and management
25. Alloimmune thrombocytopenia of the newborn: Neurodevelopmental sequelae
26. Pegylated thrombopoietin-mimetic peptides elevate blood platelets and ablate the chemotherapy-induced platelet nadir in mice
27. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy
28. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells
29. Neonatal thrombocytopenia in the hypertensive disorders of pregnancy
30. Fetal thrombocytopenia and its relation to maternal thrombocytopenia
31. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura
32. Fetal alloimmune thrombocytopenia
33. Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry study
34. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats
35. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rate model of necrotizing enterocolitis
36. Disseminated intravascular coagulation: Clinical and laboratory aspects
37. Frequency and mechanism of neonatal thrombocytopenia
38. 111In-Oxine platelet survivals in thrombocytopenic infants
39. Platelet survivals in the newborn: Effect of hypoxia
40. The use of indium-111 oxine platelet scintigraphy and survival studies in pediatric patients with thrombocytopenia
41. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: Insight into the regulation of platelet production
42. Intranuclear inclusions in megakaryocytes in congenital cytomegalovirus infection
43. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia
44. Neonatal coxsackievirus B1 infection associated with severe hepatitis: Report of three cases
45. Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count
46. Immune thrombocytopenic purpura in pregnancy: A reappraisal of management
47. The effects of antenatal drug administration on aggregation of platelets of newborn infants
48. Thrombocytopenia: A laboratory sign of septicemia in infants and children
49. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room
50. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine
51. A single intravenous dose of murine megakaryocyte growth and development factor potently stimulates platelet production challenging the necessity for daily administration
52. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the Feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens
53. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
54. Diagnosis and management of catheter-related infected intracardiac thrombosis in premature infants
55. Frequency of immune thrombocytopenia in newborns: A prospective study
56. Hereditary thrombocytopenia deafness and renal disease
57. Developmental aspects of blood hemostasis and disorders of coagulation and fibrinolysis in the neonatal period
58. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction
59. Hereditary macrothrombocytopenia nephritis and deafness
60. Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome
61. 111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricufar thrombi
62. Familiare infantile perniziosaartige Anamie (pernizioses Blutbild und Konstitution)
63. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer
64. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates
65. Disseminated intravascular and cardiac thrombosis of the neonate
66. Reactive and neoplastic disorders of megakaryocytes
67. Primary immunodeficiency diseases
68. Neonatal thrombocytopenia
69. Fanconi's anemia in a neonate
70. Thrombopoietin accelerates platelet, red blood cell and neutrophil recovery in myelosuppressed mice
71. 111In-labelled platelet scintigraphy in Kasabach-Merritt syndrome
72. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates
73. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates
74. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura
75. Thrombocytopenia with absent radii. A review of 100 cases
76. Developmental changes in human megakaryocyte ploidy
77. Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia
78. 111indium-labeled human platelets
79. 111In-oxine-labeled rabbit platelets: In vivo distribution and sites of destruction
80. Fetal thrombocytopenia: A retrospective survey of 5,194 fetal blood samplings
81. Thrombocytopenia in the neonate
82. Thrombocytopenia in neonates with trisomy 21
83. Hematologic abnormalities in severe neonatal necrotizing enterocolitis
84. Maternal and fetal outcome of pregnant women with idiopathic thrombocytopenic purpura: Retrospective analysis of 25 pregnancies
85. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura
86. 111-labeled autologous platelets
87. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin
88. Age-related changes in thrombopoietin in children: Reference interval for serum thrombopoietin levels
89. Intravascular hemolysis and thrombocytopenia in left ventricular outflow obstruction
90. Flow cytometry of neonatal platelet RNA
91. Pathology of acquired immunodeficiency syndrome (AIDS) in children
92. a) neonatal alloimmune thrombocytopenia: Clinical and immunological analysis of 39 cases
93. Thrombopoietin
94. Heparin-induced thrombocytopenia: Laboratory studies
95. Immunization against a new infrequent alloantigen (Iy) on the platelet glycoprotein Ib/IX as a cause of a serious case of neonatal alloimmune thrombocytopenia
96. Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders
97. Adhesion of percutaneously inserted Silastic central venous lines to the vein wall associated with Malassezia furfur infection
98. Incidence, neutrophil kinetics and natural history of neonatal neutropenia associated with maternal hypertension
99. The mechanism responsible for diminished neutrophil production in neonates delivered to women with pregnancy-induced hypertension
100. Association of neonatal thrombocytopenia and matenal anti-HLA antibodies
101. Morphological diagnosis of parvovirus B19 infection. A cytopathic effect easily recognized in air-dried formalin-fixed bone marrow smears stained with hematoxylin-eosin or Wright-Giemsa
102. Anti Ko(a) as a cause of neonatal alloimmune thrombocytopenia
103. Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birth weight infants
104. Serum thrombopoietin and plasma glycocalicin concentrations as useful diagnostic markers in thrombocytopenic disorders
105. The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production
106. Thrombocytopenia in a case of neonatal mumps infection: Evidence for further clinical presentations
107. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age
108. Mature micromegakaryocytes: An unusual developmental pattern in term infants
109. Safety of vancomycin with or without gentamicin in neonates
110. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
111. Thrombocytopenia in pregnant women infected with human immunodeficiency virus: Maternal and neonatal outcome
112. Transient thrombocytopenia in 18-trisomy
113. Neonatal and maternal thrombocytopenic purpura due to quinine
114. Platelet injury during phototherapy
115. Neonatal systemic candidiasis
116. Humoral regulation of erythropoiesis and thrombopoiesis in appropriate and small for gestational age infants
117. Thrombocytopenia in the high-risk infant
118. Early onset systemic Candida infection in extremely preterm neonates
119. Effect of maternal thiazides on platelet counts of newborn infants
120. Hematological abnormalities in newborn infants with Down syndrome
121. Thrombocytopenia in neonatal infection
122. Low positioning of umbilical-artery catheters increases associated complications in newborn infants
123. Nonbacterial endocardial thrombosis in neonates: Relationship to persistent fetal circulation
124. Pregnancy in women with immune thrombocytopenic purpura
125. 348 cases of suspected neonatal alloimmune thrombocytopenia
126. The central role of PAF in necrotizing enterocolitis development
127. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia
128. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates
129. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies
130. Inhibition of megakaryocytopoiesis in 'late,' sepsis-associated thrombocytopenia in preterm babies
131. 111In-labeled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: A study of 578 patients with 268 splenectomies
132. Thrombocytopenia in septicemia: The role of disseminated intravascular coagulation
133. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice
134. Mean platelet volume during coagulase-negative staphylococcal sepsis in neonates
135. Neonatal aplastic anemia and Fanconi's anemia
136. Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow
137. Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia
138. Alternative therapies for neonatal autoimmune thrombocytopenia
139. Sepsis caused by Candida in the neonatal period
140. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome
141. Hematologic abnormalities in acute necrotizin enterocolitis
142. The effect of bacteremia on automated platelet measurements in neonates
143. Reticulated platelet values in normal and thrombocytopenic neonates
144. Persistent antithrombin deficiency: Risk factor for thromboembolic complications in neonates small for gestational age
145. Increased nucleated red blood cell counts in small for gestational age infants with very low birth weight
146. Neonatal enterovirus infection
147. The mechanism of platelet release
148. Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit
149. Reticulated platelets in the evaluation of thrombopoietic disorders
150. Effect of extracorporeal membrane oxygenation on platelets in newborns
151. Neonatal thrombocytopenia associated with antepartum administration of thiazide drugs
152. Severe neonatal thrombocytopenia. Analysis of the etiologic data on 64 cases
153. Idiopathic thrombocytopenic purpura in pregnancy
154. Congenital Epstein-Barr virus infection
155. Low fetal morbidity in pregnancy assodated with acute and chronic idiopathic thrombocytopenic purpura
156. 111 platelet scintigraphy
157. Platelets and neutrophils from healthy term neonates exhibit increased levels of immunoglobulins
158. Bleeding disorders in Noonan syndrome: Three case reports and review of the literature
159. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic neonates in a neonatal intensive care unit
160. Developmental aspects of platelets and disorders of platelets in the neonatal period
161. Pharmacodynamics, pharmacokinetics, and safety of administering pegylated recombinant megakaryocyte growth and differentiation factor to newborn rhesus monkeys
162. Dose-response relationship of megakaryocyte progenitors from bone marrow and peripheral blood of thrombocytopenic neonates to recombinant thrombopoietin
163. Do plasma thrombopoietin concentrations predict the kinetic mechanism responsible for thrombocytopenia in neonates?
164. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development
165. A bone marrow biopsy technique suitable for use in neonates
166. 111In platelet scans in the detection and treatment of Kasabach-Merritt syndrome
167. Heparin-induced thrombocytopenia in the newborn
168. Malassezia furfur fungaemia in infants receiving intravenous lipid emulsions. A rarity or just underestimated?
169. Immune thrombocytopenia in severe neonatal infections
170. Neonatal thrombocytopenia and hidden maternal autoimmunity
171. Thrombocytopenia with bacterial infections in neonates
172. Interleukin-11 enhances human megakaryocytopoiesis in vitro
173. Megakaryocytopoiesis in idiopathic thrombocytopenic purpura: A morphometric and immunohistochemical study on bone marrow biopsies with special emphasis on precursor cells
174. Autologous platelet kinetics in patients with severe thrombocytopenia: Discrimination between disorders of production and destruction
175. Neonatal thrombocytopenia: Incidence serological and clinical observations
176. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice
177. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer
178. Platelet count in normal, small, and anemic fetuses
179. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis
180. Congenital parvovirus infection
181. a, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia
182. Outcomes of pregnancy in adult idiopathic thrombocytopenic purpura
183. Thrombopoietin has a primary role in the regulation of platelet production on preterm babies
184. Maternal DRBI*1501, DQAI*0102, DQBI*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489)
185. Effect of prenatal drug administration on maternal and neonatal platelet aggregation and PF4 release
186. Gancyclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study
187. Expression of the thrombopoietin gene in human fetal and neonatal tissues
188. The haematology of bacterial infection
189. New concepts in the understanding of hypertensive disease during pregnancy: An overview